Form 4: Labcorp EVP Meltzer Sells Shares After RSU Vesting

Labcorp's EVP of Operations, Jonathan C. Meltzer, reported the vesting of restricted stock units and subsequent sale of shares, including for tax obligations and under a 10b5-1 plan.

Summary

• Jonathan C. Meltzer, Executive Vice President of Operations at Labcorp Holdings Inc., reported transactions involving the company's common stock.
• On February 11, 2026, 243 shares of Common Stock were acquired due to the vesting of Restricted Stock Units.
• On February 11, 2026, 70 shares of Common Stock were disposed of at a price of $289.89 per share to satisfy tax withholding obligations.
• On February 12, 2026, 87 shares of Common Stock were disposed of at a price of $290.42 per share, pursuant to a Rule 10b5-1 trading plan.
• Following these transactions, Jonathan C. Meltzer directly beneficially owns 2,782.3256 shares of Common Stock.
• The reporting person also holds 2,694 Restricted Stock Units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, typical for executive compensation management, involving both vesting and pre-planned sales.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing, as it is a report of past insider transactions.

Industry Context

StockSavvy.ai notes that insider sales, especially those pre-planned under Rule 10b5-1 and for tax obligations, are common for executives managing their equity compensation and personal finances. These transactions do not typically signal a change in company fundamentals or outlook within the healthcare diagnostics industry.

Stakeholder Impact

• Shareholders may observe the executive's sale of shares, but given the context of RSU vesting, tax withholding, and a pre-arranged 10b5-1 plan, the impact on investor sentiment is likely minimal.

Key Dates

Recommendation

This Form 4 details routine executive compensation activities, including the vesting of restricted stock units and subsequent sales for tax obligations and under a pre-arranged 10b5-1 plan. Such transactions are common and do not typically reflect a change in the company's fundamental outlook or warrant a shift in investment strategy.

Keywords

Labcorp, LH, insider trading, Form 4, stock sale, RSU vesting, executive compensation, 10b5-1 plan, Jonathan C. Meltzer